Laura Gil Alberdi

Dr. Laura Gil Alberdi


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LALaura Gil Alberdi
Laura Gil Alberdi
Sandra A NiñoSandra A Niño
Sandra A Niño
EAErika Guadalupe Chi Ahumada
Erika Guadalupe Chi Ahumada
Ildefonso Rodriguez-LeyvaIldefonso Rodriguez-Leyva
Ildefonso Rodriguez-Leyva
GMGuerrero Marquez
Guerrero Marquez
MCMaria Jimenez Capdeville
Maria Jimenez Capdeville
Background. Recent reports point to a nuclear origin of Alzheimer’s disease (AD). Aged postmitotic neurons try to repair their damaged DNA by entering the cell cycle. This aberrant cell cycle re-entry involves chromatin modifications where nuclear Tau and the nuclear lamin are involved. The purpose of this work was to elucidate their participation in the nuclear pathological transformation of neurons at early AD. Methodology. The study was performed in hippocampal paraffin embedded sections of adult, senile, and AD brains at I-VI Braak stages. We analyzed phospho-Tau, lamins A, B1, B2, and C, nucleophosmin (B23) and the epigenetic marker H4K20me3 by immunohistochemistry. Results. Two neuronal populations were found across AD stages, one is characterized by a significant increase of Lamin A expression, reinforced perinuclear Lamin B2, elevated expression of H4K20me3 and nuclear Tau loss, while neurons with nucleoplasmic Lamin B2 constitute a second population. Conclusions. The abnormal cell cycle reentry in early AD implies a fundamental neuronal transformation. This implies the reorganization of the nucleo-cytoskeleton through the expression of the highly regulated Lamin A, heterochromatin repression and building of toxic neuronal tangles. This work demonstrates that nuclear Tau and lamin modifications in hippocampal neurons are crucial events in age-related neurodegeneration.

Verified
Journal Article
Open access
PDF file
LALaura Gil Alberdi
Laura Gil Alberdi
Sandra A NiñoSandra A Niño
Sandra A Niño
GMGuerrero Marquez
Guerrero Marquez
MCMaria Jimenez Capdeville
Maria Jimenez Capdeville
Cellular identity is determined through complex patterns of gene expression. Chromatin, the dynamic structure containing genetic information, is regulated through epigenetic modulators, mainly by the histone code. One of the main challenges for the cell is maintaining functionality and identity, despite the accumulation of DNA damage throughout the aging process. Replicative cells can remain in a senescent state or develop a malign cancer phenotype. In contrast, post-mitotic cells such as pyramidal neurons maintain extraordinary functionality despite advanced age, but they lose their identity. This review focuses on tau, a protein that protects DNA, organizes chromatin, and plays a crucial role in genomic stability. In contrast, tau cytosolic aggregates are considered hallmarks of Alzheimer´s disease (AD) and other neurodegenerative disorders called tauopathies. Here, we explain AD as a phenomenon of chromatin dysregulation directly involving the epigenetic histone code and a progressive destabilization of the tau–chromatin interaction, leading to the consequent dysregulation of gene expression. Although this destabilization could be lethal for post-mitotic neurons, tau protein mediates profound cellular transformations that allow for their temporal survival.

23 October 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
FBFrancesca Bruno
Francesca Bruno
LALaura Gil Alberdi
Laura Gil Alberdi
VSValentina Sturiale
Valentina Sturiale
CGCarmen Guerrero
Carmen Guerrero
ARAna Belen Rebolledo
Ana Belen Rebolledo
Concetta FedericoConcetta Federico
Concetta Federico
Background/Objectives: Tau protein, a central player in Alzheimer’s disease (AD) pathology, is classically known for its role in microtubule stabilisation. However, accumulating evidence indicates that tau also localises to the neuronal nucleus, particularly the nucleolus, where it may regulate chromatin organisation and transcription. In this study, we investigated whether different phosphorylation states of nuclear tau display age- and disease-dependent patterns, with a specific focus on the AT8 epitope (phospho-Ser202/Thr205). Methods: We analysed nuclear tau epitopes (Tau-1, AT8, PHF1, T181, and S262) by indirect immunofluorescence in SK-N-BE neuroblastoma cells under proliferative and retinoic acid-induced differentiated conditions and in post-mortem hippocampal CA1 neurons from foetal, young, aged, and AD brains. Other functional markers (UBTF, Ki67, fibrillarin and acetylated histone H4) were used to assess nuclear organisation and function. Results: Compared with the other epitopes, AT8 was unique in showing dynamic nuclear localisation: absent in proliferating cells but present after differentiation, abundant in young neurons, and significantly reduced in aged and AD samples. Nuclear AT8 co-localised with Ki67, and its decline was associated with neuronal cell cycle re-entry and nucleolar disorganisation. Conclusions: Among multiple nuclear tau epitopes, AT8 was the only one displaying age- and disease-related changes, and its reduction during ageing and AD correlates with nuclear stress, aberrant cell cycle activity, and neuronal vulnerability. Loss of nuclear AT8 may therefore represent an early marker of dysfunction in ageing and AD brains.

8 March 2023 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
FBFrancesca Bruno
Francesca Bruno
VSValentina Sturiale
Valentina Sturiale
DBDesiree Brancato
Desiree Brancato
LALaura Gil Alberdi
Laura Gil Alberdi
IOIsabel M Olazabal
Isabel M Olazabal
Concetta FedericoConcetta Federico
Concetta Federico
Age-related neurodegenerative diseases have drawn the interest of the scientific community due to the gradual increase in the average age in the world’s population. Recent studies have indicated an altered cell cycle in the triggering of neurodegenerative diseases such as Alzheimer’s disease (AD). This process seems to involve nuclear tau, a protein which we have previously shown to have a central role in neuronal in vitro differentiation. In this work, we studied the role of the nuclear tau protein, specifically of the AT8 epitope, in the onset of AD to evaluate its possible use as an early molecular marker. The immunolocalization in neurons of the CA1 region of the human hippocampus from normal, senile, and AD subjects showed that the AT8 epitope decreases in senile neurons with respect to younger ones, indicating its possible role in the ectopic activation of the cell cycle in differentiated cells. Here, we show data that improve knowledge on the role of nuclear tau in neuronal differentiation and cell degeneration in AD, involving the presence/absence of AT8 in the nucleolus of neurons related to re-entry into the cell cycle. The molecular mechanisms related to the start of AD are not yet clear, so their understanding is relevant if we consider the social impact of this disease in human populations.